InventisBio Co., Limited (SHSE: 688382)
Health Care · Biotechnology · CN
CN¥17.26
-9.49% today · -38.6% 1Y
InventisBio Co., Limited (SHSE: 688382) operates in the Biotechnology industry within the Health Care sector. The company is valued at $1.49B.
Over the last twelve months the share price has lost 38.6%, trading between 15.58 and 34.60.
Tweenvest scores InventisBio Co., Limited across four factors: quality 42/100, value 49/100. Its strongest factor is value.
688382 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.49B
- Revenue (TTM)
- $10.52M
- P/E
- —
- EPS
- -0.58
- Dividend yield
- —
- Beta (5Y)
- 0.26
- 52-week high
- CN¥34.60
- 52-week low
- CN¥15.58
- Avg volume (3M)
- —
- Shares outstanding
- 579.59M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Shanghai OPM Biosciences Co., Ltd.SHSE: 688293 | $1.52B | CN¥71.50 | -10.19% |
| Syndax Pharmaceuticals, Inc.NasdaqGS: SNDX | $1.52B | $16.39 | -3.53% |
| Immunocore Holdings plcNasdaqGS: IMCR | $1.51B | $29.12 | -0.92% |
| Wedge Industrial Co.,Ltd.SZSE: 000534 | $1.50B | CN¥20.79 | -3.88% |
| Staidson (Beijing) BioPharmaceuticals Co., Ltd.SZSE: 300204 | $1.47B | CN¥20.66 | +1.08% |
| Hugel, Inc.KOSDAQ: A145020 | $1.47B | ₩182,800.00 | +1.50% |
| Taysha Gene Therapies, Inc.NasdaqGS: TSHA | $1.46B | $4.19 | -6.79% |
| D&D Pharmatech Inc.KOSDAQ: A347850 | $1.46B | ₩42,850.00 | -0.35% |
Figures last refreshed Oct 11, 2026.